1. Home
  2. DVA

DVA

DaVita Inc.

Logo DaVita Inc.

Health Care

Misc Health and Biotechnology Services

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Founded: 1994 Country:
United States
United States
Employees: N/A City: DENVER
Market Cap: 11.3B IPO Year: 1995
Target Price: $117.14 AVG Volume (30 days): 838.8K
Analyst Decision: Hold Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 7.42 EPS Growth: 26.84
52 Week Low/High: $71.51 - $141.54 Next Earning Date: 05-02-2024
Revenue: $12,140,147,000 Revenue Growth: 4.57%
Revenue Growth (this year): 4.78% Revenue Growth (next year): 3.87%

Share on Social Networks: